Recital 253, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

The Commission found that the Initial Commitments were, in principle, capable of

removing the potential competition concerns identified as they reflect the current commercial position of Chr. Hansen in the markets for the production and distribution of lactase and replicate the competitive constraint it exercises.

However, the Commission highlighted that the Commitments could be further strengthened in order to ensure that the purchaser of the Divestment Business would be able to compete effectively in the market for the production of lactase.